| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000009556 |
| Receipt No. | R000011207 |
| Scientific Title | Comparison of peripheral cutting balloon versus conventional balloon angioplasty for hemodialysis vascular access stenosis ~prospective randomized controlled trial~ |
| Date of disclosure of the study information | 2012/12/15 |
| Last modified on | 2021/06/21 (Ver. 6) |
| Basic information | ||
| Public title | Comparison of peripheral cutting balloon versus conventional balloon angioplasty for hemodialysis vascular access stenosis ~prospective randomized controlled trial~ | |
| Acronym | Comparison of peripheral cutting balloon versus conventional balloon angioplasty for hemodialysis vascular access stenosis ~prospective randomized controlled trial~ | |
| Scientific Title | Comparison of peripheral cutting balloon versus conventional balloon angioplasty for hemodialysis vascular access stenosis ~prospective randomized controlled trial~ | |
| Scientific Title:Acronym | Comparison of peripheral cutting balloon versus conventional balloon angioplasty for hemodialysis vascular access stenosis ~prospective randomized controlled trial~ | |
| Region |
|
|
| Condition | |||||
| Condition | Hemodialysis vascular access stenosis | ||||
| Classification by specialty |
|
||||
| Classification by malignancy | Others | ||||
| Genomic information | NO | ||||
| Objectives | |
| Narrative objectives1 | To assess the safety and the efficacy of peripheral cutting balloon compared with conventional balloon for angioplasty of hemodialysis stenotic vascular access |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | |
| Assessment | |
| Primary outcomes | 6-month primary patency rate |
| Key secondary outcomes | Duration of primary patency of the hemodialysis vascular access
(Treatment area primary patency and access circuit primary patency) Complication Anatomical success Clinical success Procedural success Ultrasonographic finding before and after PTA(Percutaneous transluminal angioplasty) Subjective assessment of pain during balloon-cathether inflation Ultrasonographic finding at 3 months and 6 months after the intervention Angiography at 6 months |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -participants are blinded |
| Control | Active |
| Stratification | YES |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | YES |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | PTA(Percutaneous transluminal angioplasty) | |
| Interventions/Control_2 | Peripheral Cutting Balloon | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.Patient receiving hemodialysis for end stage renal disease with stenotic hemodialysis fistura or graft located on the upper extremities
2.Patient has stenotic vascular access necessary for PTA within 6 months after either surgical procedure or PTA for the stenotic lesion (PTA is indicated when vascular access stenosis is >= 50% and at least one of the clinical or physiological abnormalities are recognized) 3.PTA thought by the investigator to be the best treatment choice 4.Patient capable of providing written informed consent 5.Reference vessel for the targeted stenotic lesion with the diameter of >=3mm and <=6.5mm 6.Hemodialysis vascular access constructed more than 30 days prior to enrollment |
|||
| Key exclusion criteria | 1.Patient incapable of providing written informed consent
2.Life expectancy <6 months 3.Severe allergy to contrast medium 4.Active vascular access infection 5.Pregnancy 6.A Stent placed at the target lesion 7.An angulation of target lesion >=45 degrees 8.The reference vessel diameter <2mm 9.The target stenosis >20mm in length 10.Total occlusion 11.Severe calcification of target lesion 12.Junctional lesion needed for double guide-wire technique 13.Target lesion with branches unable to protect 14.Severely tortuous vessel proximal to the lesion 15.Multiple stenotic lesion needed for multiple sheath insertion |
|||
| Target sample size | 374 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Shizuoka General Hospital | ||||||
| Division name | Department of Nephrology | ||||||
| Zip code | 420-8527 | ||||||
| Address | Shizuoka | ||||||
| TEL | 054-247-6111 | ||||||
| mmurakami77207@gmail.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Shizuoka General Hospital | ||||||
| Division name | Department of Nephrology | ||||||
| Zip code | 420-8527 | ||||||
| Address | Shizuoka | ||||||
| TEL | 054-247-6111 | ||||||
| Homepage URL | |||||||
| mmurakami77207@gmail.com | |||||||
| Sponsor | |
| Institute | Shizuoka General Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | University of Shizuoka |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Shizuoka General Hospital |
| Address | 4-27-1 Kitaando, Aoiku, Shizuoka, Shizuoka |
| Tel | 0542476111 |
| momoko-maejima@shizuoka-pho.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011207 |